The purpose of this study was to evaluate the potential of targeting the protein kinase eEF-2K in breast tumors, with the objectives of determining whether targeting eEF-2K 1) impedes tumor growth, and 2) sensitizes tumors to chemotherapy. This evidence concerns the gene EEF2K and breast neoplasm.